Atlas Trials

A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

Clinical trial NCT06087627 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06087627
Sponsor
Sanofi
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Prurigo Nodularis
Start date
2023-12-27
Primary completion
2026-06-29
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.